Dacetuzmumab - CAS 880486-59-9
Catalog number:
880486-59-9
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
CD40
Description:
Phase II; An anti-CD40 monoclonal antibody, non-blocking, partial agonist, humanized IgG1
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
Phase II; An anti-CD40 monoclonal antibody, non-blocking, partial agonist, humanized IgG1
Synonyms:
SGN-40; huS2C6; Dacetuzumab
MSDS:
Inquire
Quality Standard:
In-house
Quantity:
Milligrams-Grams
Current Developer:
Seattle Genetics; Chemotherapy; Rituximab
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related CD40 Products


CP-870893

A potent and selective agonist of CD40; A fully human IgG2 mAb; Phase I

Dacetuzmumab
(CAS: 880486-59-9)

Phase II; An anti-CD40 monoclonal antibody, non-blocking, partial agonist, humanized IgG1

Chi Lob 7/4

An IgG1 chimeric monoclonal antibody agonist of CD40 with potential immunostimulatory and antineoplastic activities; Phase I

Quick Inquiry

Verification code

Featured Items